From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 18,227,779 shares, representing 25.26% for $588.23 million under the buyback announced on November 5, 2013.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.26 USD | +1.93% |
|
+4.57% | +26.75% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.75% | 2.15B | |
-11.68% | 11.34B | |
+27.58% | 5.65B | |
+1.44% | 5.56B | |
-17.38% | 3.77B | |
+8.12% | 2.57B | |
-64.90% | 2.39B | |
-10.17% | 2.26B | |
-12.53% | 1.7B | |
-6.29% | 1.43B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Tranche Update on Myriad Genetics, Inc.'s Equity Buyback Plan announced on November 5, 2013.